-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
NewAmsterdam Pharma Co N.V. quarterly and annual General and Administrative Expense in USD history and change rate from 31 Dec 2022 to 31 Dec 2025.
- NewAmsterdam Pharma Co N.V. General and Administrative Expense for the quarter ending 31 Dec 2025 was $3,988,000, a 9.4% increase year-over-year.
- NewAmsterdam Pharma Co N.V. General and Administrative Expense for the twelve months ending 31 Dec 2025 was $15,374,000, a 6.5% increase year-over-year.
- NewAmsterdam Pharma Co N.V. annual General and Administrative Expense for 2025 was $15,374,000, a 6.5% increase from 2024.
- NewAmsterdam Pharma Co N.V. annual General and Administrative Expense for 2024 was $14,438,000, a 12% decline from 2023.
- NewAmsterdam Pharma Co N.V. annual General and Administrative Expense for 2023 was $16,323,000, a 20% increase from 2022.